Number of individuals, cases, person-years and crude incidence rate (IR) by age at vaccination initiation and time between doses 1 and 2
| Age at first vaccination | Number of doses | Time between doses 1 and 2 (months) | Individuals (n) | Condyloma cases (n) | Person-years | Crude IR, (95% CI)* |
| ≤16 years | Two doses | 0–3 | 2 04 103 | 63 | 74 611 | 84 (66; 108) |
| 4–7 | 8095 | 8 | 8404 | 95 (48; 190) | ||
| 8+ | 1894 | 7 | 1992 | 351 (168; 737) | ||
| Three doses | 0–3 | 1 42 046 | 222 | 2 75 495 | 81 (71; 92) | |
| 4–7 | 2803 | 8 | 6619 | 121 (60; 242) | ||
| 8+ | 919 | 2 | 1646 | 121 (30; 486) | ||
| Standard dosing schedule (0, 2, 6) | 1 22 425 | 182 | 2 31 393 | 79 (68; 91) | ||
| 17–19 years | Two doses | 0–3 | 46 712 | 97 | 23 750 | 408 (335; 498) |
| 4–7 | 2965 | 6 | 3886 | 154 (69; 344) | ||
| 8+ | 615 | 6 | 995 | 603 (271; 1343) | ||
| Three doses | 0–3 | 38 705 | 197 | 93 908 | 210 (182; 241) | |
| 4–7 | 808 | 3 | 2087 | 144 (46; 446) | ||
| 8+ | 175 | 0 | 365 | - | ||
| Standard dosing schedule (0, 2, 6) | 32 015 | 146 | 76 168 | 192 (163; 225) |
*IR reported per 100 000 person-years